Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Zinc is effective for treating various skin conditions, including warts and acne.

Glutathione helps Arabidopsis roots adapt to low phosphate by regulating a specific growth pathway.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Finasteride doesn't affect bone density in male rats.

Bald men are not more virile and may have fewer sexual partners.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

New genes and pathways are important for testosterone production and male sexual development.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Ficus benghalensis leaf extracts can effectively promote hair growth and inhibit hair loss.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Androgens, like testosterone, are crucial for early testicular descent in rats.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.